Skip to main content
. 2020 Aug 22;8(3):469. doi: 10.3390/vaccines8030469

Figure 1.

Figure 1

Crude incidences of invasive meningococcal disease in children 0–5 years of age pre and post introduction of 4CMenB in Tuscany (A) or Veneto (B). In Tuscany, 3 out of 4 cases of Invasive Meningococcal Disease (IMD) and in Veneto 5 out of 7 cases of IMD in the post-4CMenB era occurred in not-vaccinated children. Abbreviations: MenB: Neisseria meningitides serogroup B; 4CMenB = multicomponent meningococcal serogroup B vaccine.